B2Gold Corp (BTO)
Toronto Stock Exchange · Canada · prices in CAD · close of 27 Oct 2026
Key indicators
| Last close | CAD 6.980 |
|---|---|
| 52-week range | 5.015 – 8.600 |
| Return, 1 month / 3 months | −9.7% / +28.5% |
| Return, 1 year / 3 years | +2.1% / +72.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 58.9% |
| Worst drawdown (1 year) | -38.9% |
| Average daily value traded | 30.54M CAD |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
B2Gold Corp is a gold mining company based in Vancouver, Canada. It explores for, develops and operates gold mines in several countries, including Mali, Namibia, Burkina Faso and the Philippines. The company produces gold in the form of doré bars and concentrate, which it delivers to refiners and other buyers in the global gold market. Its operations span open-pit and underground mining, along with processing plants that turn mined ore into a saleable gold product.
The shares are listed on the Toronto Stock Exchange in Canada under the code BTO, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
B2Gold Corp (BTO) trades on the Toronto Stock Exchange in Canada. It last closed at CAD 6.980 on 27 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 279 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.1% and over the last three months it rose 28.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.9% | ||
| From 52-week high | -17.6% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 28.5% | ||
| 6-month return | 13.6% | ||
| 12-month return, skipping the last month | 13.1% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.9% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 30.54M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.4% |
|---|---|
| 1 month | −9.7% |
| 3 months | +28.5% |
| 6 months | +13.6% |
| 1 year | +2.1% |
| 3 years | +72.3% |
| 5 years | +56.6% |
Signals
| 50-day / 200-day average | 7.428 / 6.655 |
|---|---|
| Golden / death cross (60 days) | Golden, 29 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.283 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | CAD 0.0280 |
| 10 Jun 2026 | CAD 0.0280 |
| 6 Mar 2026 | CAD 0.0270 |
| 2 Dec 2025 | CAD 0.0280 |
| 10 Sep 2025 | CAD 0.0280 |
| 11 Jun 2025 | CAD 0.0270 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.